FDA Advisory Panel Backs Compounding Use for Select Peptides

By Ed Silverman · STAT News · 2026-07-27

FDA Advisory Panel Backs Compounding Use for Select Peptides

An advisory committee for the FDA recently signaled support for compounding pharmacies to produce epitalon and semax, according to reporting from STAT News. While the panel rejected a proposal for emideltide, these developments align with a broader push by federal health official

An advisory committee for the FDA recently signaled support for compounding pharmacies to produce epitalon and semax, according to reporting from STAT News. While the panel rejected a proposal for emideltide, these developments align with a broader push by federal health official